FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Stay Up-to-Date On Environmental Management, Energy & Sustainability News with EL's Free Daily Newsletter
Energy Manager News
- Bridgewater, MA, Gets $231,000 Efficiency Grant
- Biomass Group Studies Role in Clean Power Plan
- Rockleigh Borough Installing LEDs, Low Energy AC
- PHG to Build Big Gasification Plant for Sevier Solid Waste
- Energy Profile of Commercial Buildings Changing
- Smart Meter Market Surging
- Modular Data Centers Cut Construction Costs
- Failure to Build Energy Infrastructure Could Cost New England $5.4B